Association between hypertension and the prevalence of liver steatosis and fibrosis

BMC Endocrine Disorders

Table 1 The characteristics of the participants

	Non-hypertension	hypertension	P-value
Age (years)	46.8 ± 16.5	62.1 ± 13.4	< 0.001
Sex (%)			0.584
Men	49.0	49.8
Women	51.0	50.2
Race			< 0.001
Non-Hispanic White	33.6	38.0
Non-Hispanic Black	23.2	31.0
Mexican American	13.9	8.6
Other race	29.3	22.4
Education level			< 0.001
Less than high school	18.5	19.9
High school	22.7	27.0
More than high school	58.7	52.8
Body mass index (kg/m2)	29.0 ± 7.0	31.2 ± 7.3	< 0.001
Ratio of family income to poverty	2.7 ± 1.6	2.6 ± 1.6	0.020
Smoked at least 100 cigarettes in life (%)			< 0.001
Yes	33.5	45.6
No	66.4	54.4
Glycohemoglobin (%)	5.7 ± 1.0	6.2 ± 1.2	< 0.001
Serum glucose (mmol/L)	6.0 ± 1.7	6.8 ± 2.5	< 0.001
Alkaline phosphatase (U/L)	76.5 ± 23.8	81.9 ± 26.3	< 0.001
Alanine amino transferase (IU/L)	21.6 ± 15.7	21.7 ± 20.2	0.319
Aspartic acid transferase (IU/L)	21.2 ± 12.1	21.6 ± 15.4	0.379
Gamma-glutamyl transpeptidase (IU/L)	28.1 ± 33.5	32.8 ± 42.5	< 0.001
Serum uric acid (umol/L)	305.8 ± 79.5	340.4 ± 91.5	< 0.001
Blood urea nitrogen (mmol/L)	5.0 ± 1.6	6.0 ± 2.6	< 0.001
Total cholesterol ((mmol/L)	4.9 ± 1.0	4.8 ± 1.1	< 0.001
Triglyceride	1.2 ± 1.4	1.4 ± 1.1	< 0.001
LDL Cholesterol	2.9 ± 0.9	2.8 ± 0.9	< 0.001
Median controlled attenuation parameter (dB/m)	257.1 ± 60.3	279.4 ± 61.3	< 0.001
Liver steatosis (%)			< 0.001
Yes	38.6	53.3
No	61.4	46.7
Median liver stiffness (kpa)	5.5 ± 4.4	6.5 ± 5.4	< 0.001
Significant fibrosis (%)			< 0.001
Yes	7.5	15.3
No	92.5	84.7

Continuous variables were presented as the mean ± SD, and P-values were determined by performing the Kruskal-Wallis H test (skewed distribution) and one-way ANOVA (normal distribution). Categorical variables were presented as a percentage, and the P-values were determined by performing a Chi-squared test

ISSN: 1472-6823